| 3. MANUFACTURING OPERATIONS - ACTIVE SUBSTANCES |
Active Substance:L-Histidine |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Phenylalanine |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Serine |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Threonine |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Isoleucine |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Tryptophan |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Valine |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Methionine |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Mono sodium glutamate |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Glutamic acid |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:DL-Serine |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Leucine |
|
3.2
|
Extraction of Active Substance from Natural Sources
|
| |
| 3.2.6 Purification of extracted substance Animal Plant |
|
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Tyrosine |
|
3.2
|
Extraction of Active Substance from Natural Sources
|
| |
| 3.2.6 Purification of extracted substance Animal Plant |
|
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Aspartic acid |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Filtration, crystallization
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:D,L-Aspartic acid |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Filtration, crystallization
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Lysine acetate |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Filtration, crystallization
|
|
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Betaine Anhydrous |
|
3.2
|
Extraction of Active Substance from Natural Sources
|
| |
| 3.2.6 Purification of extracted substance Plant |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Malic acid |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: filtration, crystallization
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Asparagine (anhydrous, monohydrate) |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Filtration, crystallization
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Alanine |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Filtration, crystallization
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Cystine |
|
3.2
|
Extraction of Active Substance from Natural Sources
|
| |
| 3.2.6 Purification of extracted substance Animal |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Glycine |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Filtration, crystallization
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:N-Acetyl-L-Tyrosine |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: Filtration, crystallization
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Taurine |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: filtration, crystallization
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Arginine |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Arginine hydrochloride |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Histidine hydrochloride monohydrate |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:L-Lysine hydrochloride |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|